Transient Hyperprolactinemia Associated With Semaglutide in a Patient With Hashimoto’s Thyroiditis
Gabriela N F Guimarães, Semonti Nandi · 2026
Read Transient Hyperprolactinemia Associated With Semaglutide in a Patient With Hashimoto’s Thyroiditis by Gabriela N F Guimarães, Semonti Nandi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213196.txt.
Description
Gabriela N. F. Guimarães and Semonti Nandi report in 2026 a woman whose prolactin hormone rose sharply while she took the weight-loss and diabetes drug semaglutide, then settled once she stopped. She also lived with a well-controlled underactive thyroid condition.
Her prolactin approached a level that often triggers a search for a pituitary tumour, yet she had no symptoms and a scan showed no growth. No other treatment was needed, because levels normalised after the drug ended. The authors suggest the drug class may nudge prolactin control through brain pathways in susceptible people. Clinicians, they advise, should consider medicines before assuming a tumour explains a high reading.
Catalog record
| CREATOR | Gabriela N F Guimarães, Semonti Nandi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |